España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BioNTech
BNTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$123.77
2.89
2.39%
At close: -
$124.78
1.01
0.82%
After Hours: Jan 31, 6:47 PM EDT
Get Report
Comment
BioNTech (BNTX) Forecast
News
Earnings
BioNTech (BNTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for BioNTech (NASDAQ:BNTX) Stock
BioNTech Stock (NASDAQ: BNTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 29, 2025
Trump Health Sec Nominee Kennedy Appears In F...
Benzinga Newsdesk
Benzinga Market Summary: S&P Slips Ahead Of F...
Benzinga Newsdesk
Tuesday, January 28, 2025
Peering Into BioNTech's Recent Short Interest
Benzinga Insights
Shares of vaccine stocks are trading higher. ...
Benzinga Newsdesk
"RFK Jr. Says He's Not Anti-Vaccine, Sees Cri...
Benzinga Newsdesk
Sunday, January 19, 2025
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, January 14, 2025
BioNTech Shares Pipeline Advances, Including ...
Benzinga Newsdesk
Monday, January 13, 2025
Why BioNTech (BNTX) Shares Are Volatile Today
Henry Khederian
Shares of vaccine stocks are trading lower af...
Benzinga Newsdesk
Friday, January 10, 2025
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Vandana Singh
Truist Securities Initiates Coverage On BioNT...
Benzinga Newsdesk
Tuesday, January 07, 2025
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Vandana Singh
Shares of vaccine makers are trading higher a...
Benzinga Newsdesk
Shares of vaccine makers are trading higher a...
Benzinga Newsdesk
Friday, December 27, 2024
BioNTech Entered Settlement Agreement With NI...
Benzinga Newsdesk
BioNTech Entered $467M Settlement Agreement W...
Benzinga Newsdesk
Wednesday, December 11, 2024
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Benzinga Insights
BioNTech shares are trading higher after Well...
Benzinga Newsdesk
Wells Fargo Initiates Coverage On BioNTech wi...
Benzinga Newsdesk
Friday, December 06, 2024
Why Is BioNTech Stock Trading Higher On Friday?
Vandana Singh
BioNTech shares are trading higher after the ...
Benzinga Newsdesk
Reported Earlier, Duality Biologics And BioNt...
Benzinga Newsdesk
Tuesday, November 26, 2024
JP Morgan Maintains Neutral on BioNTech, Lowe...
Benzinga Newsdesk
Thursday, November 21, 2024
Watching Shares Of Vaccine Stocks; Traders Ci...
Benzinga Newsdesk
Wednesday, November 20, 2024
U.S. CDC Says Flu, Covid-19, RSV Illnesses Ar...
Benzinga Newsdesk
Tuesday, November 19, 2024
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
BioNTech shares are trading higher after Ever...
Benzinga Newsdesk
Evercore ISI Group Upgrades BioNTech to Outpe...
Benzinga Newsdesk
Monday, November 18, 2024
Canaccord Genuity Maintains Buy on BioNTech, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioNTec...
Benzinga Newsdesk
Friday, November 15, 2024
BioNTech's Options: A Look at What the Big Money is Thinking
Benzinga Insights
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
The Arora Report
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Vandana Singh
Shares of vaccine stocks are trading lower Af...
Benzinga Newsdesk
Thursday, November 14, 2024
Donald Trump Jr. Posts On X "Robert F Kennedy...
Benzinga Newsdesk
Shares of vaccine stocks are trading lower fo...
Benzinga Newsdesk
'Trump Expected To Select Robert F. Kennedy J...
Benzinga Newsdesk
The Analyst Landscape: 17 Takes On BioNTech
Benzinga Insights
Canaccord Genuity Maintains Buy on BioNTech, ...
Benzinga Newsdesk
Wednesday, November 13, 2024
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
Vandana Singh
BioNTech shares are trading higher after the ...
Benzinga Newsdesk
BioNTech Has Agreed To Acquire Biotheus For $...
Benzinga Newsdesk
Saturday, November 09, 2024
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
Vandana Singh
Friday, November 08, 2024
What Analysts Are Saying About BioNTech Stock
Benzinga Insights
BioNTech shares are trading higher after Gold...
Benzinga Newsdesk
This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Avi Kapoor
Goldman Sachs Upgrades BioNTech to Buy, Raise...
Benzinga Newsdesk
Thursday, November 07, 2024
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Erica Kollmann
Wednesday, November 06, 2024
Breaking Down BioNTech: 16 Analysts Share Their Views
Benzinga Insights
TD Cowen Maintains Hold on BioNTech, Lowers P...
Benzinga Newsdesk
Show More
